ArticleFrontiers in surgery2022

ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma.

Chiyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.